Psilocybin study offers hope for chronic migraine sufferers

Budding research into the potential use of psilocybin, a psychedelic, to treat migraine disorders has returned positive results. The new study from Yale School of Medicine is the first of its kind to investigate this potential use for psilocybin using a double-blind placebo-controlled cross-over study. The results, though preliminary, are promising. While the past several years have seen interest in … Continue reading